Geoff Meacham
Stock Analyst at B of A Securities
(3.93)
# 626
Out of 4,980 analysts
258
Total ratings
57.67%
Success rate
7.75%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $10 → $14 | $10.51 | +33.21% | 3 | Aug 28, 2025 | |
| VIR Vir Biotechnology | Upgrades: Buy | $12 → $14 | $5.24 | +167.18% | 3 | Aug 27, 2025 | |
| ABOS Acumen Pharmaceuticals | Maintains: Buy | $10 → $9 | $1.44 | +525.00% | 5 | Aug 25, 2025 | |
| AMGN Amgen | Maintains: Neutral | $305 → $310 | $279.97 | +10.73% | 13 | Aug 6, 2025 | |
| BIIB Biogen | Maintains: Neutral | $125 → $135 | $143.60 | -5.99% | 15 | Aug 1, 2025 | |
| PTCT PTC Therapeutics | Maintains: Neutral | $40 → $50 | $58.42 | -14.41% | 9 | Jul 28, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $79 → $78 | $53.69 | +45.28% | 3 | Jul 22, 2025 | |
| RPRX Royalty Pharma | Maintains: Buy | $40 → $42 | $36.50 | +15.07% | 3 | Jul 22, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Buy | $50 → $54 | $53.50 | +0.93% | 6 | Jun 25, 2025 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $72 | $58.36 | +23.37% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $26.60 | +57.89% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $72.04 | +52.69% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $6 | $7.96 | -24.62% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $75 | $46.62 | +60.88% | 6 | Jun 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $650 | $556.53 | +16.80% | 22 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $210 → $205 | $210.42 | -2.58% | 17 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $47 → $44 | $43.48 | +1.20% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $102.09 | +37.13% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $1.67 | -40.12% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $40 | $24.47 | +63.47% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $36.86 | +8.52% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $38.46 | +147.01% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $8.63 | +189.69% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $55.69 | +84.95% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $3.58 | +11.73% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $115.76 | +7.98% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $396.48 | +45.03% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $750.61 | +46.55% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $13.32 | +50.21% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $11.82 | +162.27% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $84.61 | +71.37% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $176.96 | -3.93% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $23.78 | +101.85% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $47.23 | +27.04% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.38 | +48.70% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.50 | +3,304.08% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $24.71 | +82.11% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $2.75 | +772.73% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $4.26 | -6.10% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.61 | +1,639.13% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.50 | +6,660.79% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $8.58 | +552.68% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $2.54 | +1,277.95% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $2.58 | +20,248.84% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.60 | +2,525.00% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $7.65 | +161.61% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.52 | +3,748.37% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $4.71 | +91.08% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $9.86 | +508.83% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $4.11 | +70.52% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $15.23 | +51.02% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $85.60 | -4.21% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $403.80 | -76.47% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.40 | +751.06% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $144.17 | -6.36% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $8.35 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $1.11 | +1,701.80% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $14.48 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $482.13 | -67.23% | 5 | Nov 8, 2017 |
Amylyx Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $10.51
Upside: +33.21%
Vir Biotechnology
Aug 27, 2025
Upgrades: Buy
Price Target: $12 → $14
Current: $5.24
Upside: +167.18%
Acumen Pharmaceuticals
Aug 25, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $1.44
Upside: +525.00%
Amgen
Aug 6, 2025
Maintains: Neutral
Price Target: $305 → $310
Current: $279.97
Upside: +10.73%
Biogen
Aug 1, 2025
Maintains: Neutral
Price Target: $125 → $135
Current: $143.60
Upside: -5.99%
PTC Therapeutics
Jul 28, 2025
Maintains: Neutral
Price Target: $40 → $50
Current: $58.42
Upside: -14.41%
CRISPR Therapeutics AG
Jul 22, 2025
Maintains: Buy
Price Target: $79 → $78
Current: $53.69
Upside: +45.28%
Royalty Pharma
Jul 22, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $36.50
Upside: +15.07%
BridgeBio Pharma
Jun 25, 2025
Maintains: Buy
Price Target: $50 → $54
Current: $53.50
Upside: +0.93%
Protagonist Therapeutics
Jun 17, 2025
Initiates: Buy
Price Target: $72
Current: $58.36
Upside: +23.37%
Jun 17, 2025
Initiates: Buy
Price Target: $42
Current: $26.60
Upside: +57.89%
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $72.04
Upside: +52.69%
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $7.96
Upside: -24.62%
Jun 10, 2025
Maintains: Buy
Price Target: $70 → $75
Current: $46.62
Upside: +60.88%
Jun 2, 2025
Maintains: Buy
Price Target: $700 → $650
Current: $556.53
Upside: +16.80%
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $210.42
Upside: -2.58%
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $43.48
Upside: +1.20%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $102.09
Upside: +37.13%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $1.67
Upside: -40.12%
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $24.47
Upside: +63.47%
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $36.86
Upside: +8.52%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $38.46
Upside: +147.01%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $8.63
Upside: +189.69%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $55.69
Upside: +84.95%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $3.58
Upside: +11.73%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $115.76
Upside: +7.98%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $396.48
Upside: +45.03%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $750.61
Upside: +46.55%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $13.32
Upside: +50.21%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $11.82
Upside: +162.27%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $84.61
Upside: +71.37%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $176.96
Upside: -3.93%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $23.78
Upside: +101.85%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $47.23
Upside: +27.04%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.38
Upside: +48.70%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.50
Upside: +3,304.08%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $24.71
Upside: +82.11%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $2.75
Upside: +772.73%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $4.26
Upside: -6.10%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.61
Upside: +1,639.13%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.50
Upside: +6,660.79%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $8.58
Upside: +552.68%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $2.54
Upside: +1,277.95%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $2.58
Upside: +20,248.84%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.60
Upside: +2,525.00%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $7.65
Upside: +161.61%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.52
Upside: +3,748.37%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $4.71
Upside: +91.08%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $9.86
Upside: +508.83%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $4.11
Upside: +70.52%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $15.23
Upside: +51.02%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $85.60
Upside: -4.21%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $403.80
Upside: -76.47%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.40
Upside: +751.06%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $144.17
Upside: -6.36%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $8.35
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $1.11
Upside: +1,701.80%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $14.48
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $482.13
Upside: -67.23%